THERAPY DOSSIER · th-06f024ce4610
Autologous keratinocytes
Drug
Approved for trauma (caveats) Suggest a correction
Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Not recorded
- Reported indication
- Burns, chronic wounds
- First approval
- Not recorded
- Development stage
- Approved (with caveats)
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Cultured epidermal autografts for deep or extensive burns (e.g. Epicel, FDA Humanitarian Device Exemption H990002). Classified as a device/biologic, not a drug, and excluded from drug denominators.
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 0
0 studies reported at therapy level; 0 evidence entries itemised.
Individual study details are not itemised for this therapy.